
Moxytrack-CV 625 Tablet
Marketer
Welltrack Pharma
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Moxytrack-CV 625 Tablet
Cephalexin 625mg tablets are antibacterial medications combating bacterial infections. They effectively treat lung (pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections. This medication is ineffective against viral illnesses like the common cold. For optimal absorption and minimized stomach discomfort, take Cephalexin 625mg with food, adhering strictly to your physician's prescribed dosage schedule. Consistent, evenly spaced doses improve adherence. The prescribed amount will vary depending on the infection; however, always complete the full course of treatment. Premature discontinuation may allow surviving bacteria to re-establish the infection. Common side effects, typically mild, include nausea, diarrhea, vomiting, oral or vaginal thrush, skin rashes, and vaginitis. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any antibiotic allergies, kidney or liver issues, and all other medications you are currently using, as interactions may occur. This medication is generally considered safe during pregnancy and breastfeeding under medical supervision.
Uses of Moxytrack-CV 625 Tablet
Managing bacterial illnesses
Major Benefits of Moxytrack-CV 625 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Moxytrack-CV 625 Tablet with a meal.
Common Side effects of Moxytrack-CV 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Moxytrack-CV 625 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take Moxytrack-CV 625 Tablet with food.
How Moxytrack-CV 625 Tablet works:
Amoxycillin and clavulanate potassium, combined as Moxytrack-CV 625 Tablet, offer a dual-action approach to bacterial infection. Amoxycillin, an antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. The addition of clavulanate potassium, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus maximizing Amoxycillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Moxytrack-CV 625 Tablet with alcohol.
PregnancySAFE IF PRESCRIBED
The use of Moxytrack-CV 625 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Moxytrack-CV 625 Tablet is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Moxytrack-CV 625 Tablets, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Moxytrack-CV 625 Tablets, as dosage modification may be necessary. Physician consultation is advised. The medication is contraindicated for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Moxytrack-CV 625 Tablets, as dose modification may be necessary. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.
What if you forget to take Moxytrack-CV 625 Tablet :
Should you forget a dose of Moxytrack-CV 625 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Moxytrack-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
